MECHANISM FOR SIGNAL TRANSDUCTION OF OPIOID RECEPTOR STIMULATION OF MYOCYTES
阿片受体刺激心肌细胞的信号转导机制
基本信息
- 批准号:3789781
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:biological signal transduction calcium channel calcium flux calcium metabolism enkephalins heart cell heart contraction heart pharmacology heart ventricle laboratory rat leucine mature animal myocardium naloxone neurotransmitter metabolism opioid receptor sarcolemma sarcoplasmic reticulum stimulant /agonist voltage /patch clamp
项目摘要
The recent discovery of the presence of opioid peptide receptors on
cardiac ventricular cells has prompted investigation of functional effects
that result from stimulation of these receptors. In this regard, a
naturally occurring opioid peptide, Leucine enkephalin (Leuenk), a delta
receptor agonist, leads to a marked reduction in the twitch amplitude of
single adult rat ventricular myocytes. This effect is due, in large part,
to a reduction in the amplitude of the cytosolic Ca2+ transient (Cai).
The Cai transient following the excitation of heart cells is due to
activation of L-type sarcolemmal Ca2+ channels leading to Ca2+ influx via
these channels (ICa). This Ca2+ influx triggers Ca2+ release from the
sarcoplasm reticulum (SR) and also loads the SR with Ca2+ for subsequent
releases. The specific mechanism by which Cai is reduced by Leuenk have
been partly elucidated. Leuenk causes a release of Ca2+ from the SR and
leads to a reduction in the amount of Ca2+ in the SR stores. These
effects may be attributable to an increase in IP3 and IP4 produced by
Leuenk. However, it is unknown whether Leuenk also decreases ICa. In
this regard, the effect of opioid peptides to block neurotransmitters
release from neurons has been attributed to a reduction in Ca2+ channel
current in these cells. In the present study we determined the effect of
Leuenk on ICa of individual cardiac ventricular cells freshly isolated
from adult rats. ICa was measured via patch pipette in the whole cell
voltage clamp mode. We observed that Leuenk (10-7M) decreases the
amplitude of ICa by 40% during regular stimulation at 0.2 Hz at 23 degree
C. Thus the ICa IV relation was not altered by Leuenk. The ICa
depression by Leuenk was abolished by Naloxone, a specific k receptor
antagonist. The ICa inactivation kinetics were unaffected by Leuenk.
That Leuenk decreases the magnitude of ICa indicates that stimulation of
delta opioid receptors leads to both a reduction in the magnitude of the
trigger for Ca2+ release and to a reduction in Ca2+ loading of the SR.
Thus, the opioid peptide effects to decrease the Cai transient and
contraction amplitudes in individual cardiac ventricular cells, are, in
part, due to a reduction in ICa.
最近发现了阿片肽受体的存在
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
E LAKATTA其他文献
E LAKATTA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('E LAKATTA', 18)}}的其他基金
REGULATION OF LEFT VENTRICULAR VOLUMES AT REST AND DURING STRESS
静息时和应激时左心室容积的调节
- 批准号:
3789784 - 财政年份:
- 资助金额:
-- - 项目类别:
NOVEL CARDIAC MYOFILAMENT DESENSITIZING SUBSTANCE RELEASED BY ENDOCARDIAL CELLS
心内膜细胞释放的新型心肌肌丝脱敏物质
- 批准号:
3745560 - 财政年份:
- 资助金额:
-- - 项目类别:
AUTONOMIC MODULATION OF RESTING AND EXERCISE CARDIAC PERFORMANCE
静息和运动时心脏功能的自主调节
- 批准号:
3745459 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
L-type Calcium Channel SNP rs1006737: characterizing the genetic risks in MUD (Methamphetamine Use Disorder)
L 型钙通道 SNP rs1006737:表征 MUD(甲基苯丙胺使用障碍)的遗传风险
- 批准号:
10668210 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Development of a Novel Calcium Channel Therapeutic for the Treatment of Asthma
开发治疗哮喘的新型钙通道疗法
- 批准号:
10603554 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Development of a Novel Calcium Channel Therapeutic for Opioid Use Disorder
开发一种治疗阿片类药物使用障碍的新型钙通道疗法
- 批准号:
10684558 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase
使用 T 型钙通道和可溶性环氧化物水解酶的活性 IND 双重抑制剂开发治疗酒精使用障碍的新型药物
- 批准号:
10815882 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Novel Tools to Probe Trafficking and Function of Calcium Channel Signaling Complexes in Heart
探测心脏钙通道信号复合物的运输和功能的新工具
- 批准号:
10628914 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Mechanisms of L-type Calcium Channel Regulation in Heart Health and Disease
L 型钙通道在心脏健康和疾病中的调节机制
- 批准号:
10734121 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Structure-Function of Calcium Channel Complexes in Cardiac Physiology and Disease
钙通道复合物在心脏生理和疾病中的结构-功能
- 批准号:
10628911 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Research Initiation Award: Defining the role of DJ-1 in regulating L-type voltage-dependent calcium channel expression in neuronal plasticity
研究启动奖:定义 DJ-1 在调节神经元可塑性中 L 型电压依赖性钙通道表达中的作用
- 批准号:
2200474 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Standard Grant
Design and Preclinical Development of First-in-Class Selective T-type Calcium Channel Blockers for Chronic Pain
用于治疗慢性疼痛的一流选择性 T 型钙通道阻滞剂的设计和临床前开发
- 批准号:
452107 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Operating Grants
Preventing the Calcium Channel Blocker – Lower Extremity Edema – Loop Diuretic Prescribing Cascade in Older Adults
预防钙通道阻滞剂 – 下肢水肿 – 老年人袢利尿剂处方级联
- 批准号:
10399417 - 财政年份:2021
- 资助金额:
-- - 项目类别: